NYSE · STEHealthcareOrthopedic & Surgical Supplies

STERIS financials

$210.65−0.17%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Mar 31
FY25
Mar 31
FY24
Mar 31
FY23
Mar 31
FY22
Mar 31
FY21
Mar 31
FY20
Mar 31
FY19
Dec 31
Revenue$5.94B$5.46B$5.14B$4.54B$4.22B$3.11B$3.03B$2.78B
Gross profit$2.63B$2.40B$2.22B$1.98B$1.88B$1.34B$1.32B$1.17B
Gross margin44.2%44.0%43.2%43.7%44.6%43.2%43.6%42.2%
Operating income$1.10B$866.6M$836.2M$791.1M$477.8M$548.4M$537.0M$411.0M
Net income$782.3M$614.6M$378.2M$107.0M$243.9M$397.4M$407.7M$303.7M
Net margin13.2%11.3%7.4%2.4%5.8%12.8%13.5%10.9%
Diluted EPS$7.93$6.20$3.81$1.07$2.48$4.63$4.76$3.55
EBITDA$1.59B$1.39B$1.43B$1.37B$1.03B$764.7M$735.0M$667.9M
Operating cash flow$1.34B$1.15B$973.3M$756.9M$684.8M$689.6M$590.6M$539.5M
Free cash flow$972.4M$778.0M$613.0M$395.0M$397.2M$450.4M$376.0M$349.8M
Diluted shares98.7M99.1M99.4M100.2M98.3M85.9M85.6M85.5M

Balance sheet

Period endMar 31Mar 31Mar 31Mar 31Mar 31Mar 31
Cash & equivalents$439.6M$171.7M$207.0M$208.4M$348.3M$220.5M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$1.93B$2.04B$3.21B$3.08B$3.09B$1.67B
Total assets$10.74B$10.15B$11.06B$10.82B$11.42B$6.57B
Total liabilities$3.54B$3.53B$4.75B$4.73B$4.88B$2.68B
Shareholders' equity$7.20B$6.62B$6.32B$6.09B$6.54B$3.89B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology